Arab Company for Asset Management and Development (ACAMD) received an offer to sell its 58,000-square-meter land in Minya governorate, according to the company’s statement filed to the Egyptian Exchange.

GlaxoSmithKline (GSK - Egypt) (BIOC) said the Hikma Pharmaceuticals would not submit a Mandatory Tender Offer (MTO) to acquire GSK-Egypt, according to the company’s statement to the Egyptian Exchange.

Egyptian Starch and Glucose Company (ESGC) will write off its shares from the Egyptian Exchange (EGX) and buy back the shares from shareholders who dissented to the delisting, according to the company’s disclosure filed to the EGX.

Macro Group Pharma plans to go for an initial public offering (IPO) in the first quarter (Q1) or the second quarter (Q2) of 2021, becoming Egypt’s second IPO this year, Enterprise reported.